Viemed Healthcare, Inc. VMD
8.91
0.09
1.02%
as of 25 Sep
- Market cap
- $335.9M
- P/E
- 23.4×
Follow VMD
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
1,104,377.10 | 8.05 | 267,500.00 | 26.36 | 9.58 | 22.70 | 50.33 | 29.59 | 27.66 | 19.05 |
P/S ratio |
0.00 | 0.00 | 12,483.42 | 2.91 | 2.29 | 1.76 | 2.10 | 1.67 | 1.39 | 1.07 |
P/FCF ratio |
0.00 | 0.00 | 47,741.55 | 37.26 | 11.00 | 61.59 | 49.36 | 14.12 | 26.70 | 10.29 |
P/Operating CF |
0.00 | 0.00 | 99,293.81 | 31.60 | 51.92 | 23.82 | 37.98 | 23.07 | 20.74 | 15.67 |
P/B ratio |
0.00 | 0.00 | 25,016.27 | 5.35 | 3.68 | 2.17 | 3.01 | 2.69 | 2.33 | 2.01 |
Price to Tangible BV |
0.00 | 0.00 | 25,016.27 | 5.35 | 3.68 | 2.17 | 3.01 | 3.67 | 3.12 | 3.47 |
EV/Sales |
0.00 | 0.00 | 12,483.26 | 2.90 | 2.12 | 1.57 | 1.99 | 1.64 | 1.33 | 1.07 |
EV/EBITDA |
0.00 | 0.00 | 55,161.80 | 14.91 | 9.24 | 8.46 | 11.86 | 8.19 | 7.12 | 5.84 |
EV/Operating CF |
0.00 | 0.00 | 36,426.81 | 12.20 | 7.92 | 8.17 | 9.93 | 6.65 | 7.61 | 5.54 |
EV/FCF |
0.00 | 0.00 | 47,740.96 | 37.11 | 10.18 | 54.91 | 46.61 | 13.86 | 25.54 | 10.25 |
Quick Ratio |
1.00 | 1.13 | 0.98 | 0.96 | 1.88 | 2.42 | 1.71 | 0.97 | 1.14 | 0.96 |
Current Ratio |
1.22 | 1.29 | 1.18 | 1.07 | 2.05 | 2.66 | 2.11 | 1.19 | 1.42 | 1.18 |
Net Debt/EBITDA |
1.20 | 0.01 | (0.50) | (0.06) | (0.75) | (1.03) | (0.70) | (0.15) | (0.32) | (0.02) |
Debt/Assets |
26.30% | 13.77% | 6.41% | 15.03% | 7.46% | 5.13% | 0.59% | 4.65% | 2.26% | 6.22% |
Debt/Equity |
0.50 | 0.22 | 0.11 | 0.28 | 0.10 | 0.06 | 0.01 | 0.06 | 0.03 | 0.09 |
Asset Turnover |
0.99 | 1.51 | 1.41 | 1.18 | 1.35 | 1.02 | 1.18 | 1.35 | 1.35 | 1.44 |
Operating CF/Net income |
5.22 | 1.47 | 2.35 | 2.24 | 1.11 | 2.46 | 4.46 | 4.41 | 3.47 | 3.48 |
Capex/Depreciation |
0.00 | (1.40) | (1.40) | (2.00) | (0.81) | (1.69) | (1.40) | (1.08) | (1.07) | (0.83) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 6.59% | 44.75% | 33.77% | 22.35% | 50.29% | 10.34% | 6.48% | 9.71% | 9.11% | 10.79% | |
| 3.87% | 26.29% | 20.82% | 12.51% | 32.31% | 7.92% | 5.30% | 7.53% | 6.79% | 7.94% | |
ROIC |
0.00% | 23.14% | 24.86% | 13.48% | 21.68% | 8.97% | 5.88% | 8.59% | 8.44% | 8.98% |
Return on Tangible Assets |
7.82% | 33.31% | 27.90% | 15.04% | 39.80% | 9.88% | 7.02% | 12.83% | 12.27% | 17.32% |
Average Days of Receivables |
56.47 | 76.08 | 50.05 | 52.46 | 34.39 | 45.88 | 40.50 | 36.80 | 40.55 | 34.86 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 1.06% | 0.82% | 1.80% | 1.94% | 1.52% | 1.37% | 1.12% |
Selling, General and Administrative Expense of Revenue |
74.06% | 54.10% | 57.41% | 56.40% | 43.95% | 51.29% | 52.84% | 51.22% | 50.16% | 48.28% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | 0.19 | 0.30 |
Share Based Compensation of Revenue |
0.00% | 1.76% | 4.19% | 4.84% | 3.72% | 4.40% | 3.75% | 3.20% | 2.80% | 3.38% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | (0.05) | 0.05 | 0.12 | 0.07 | (0.01) | 0.03 | (0.02) |
Graham Number |
0.00 | 0.00 | 2.27 | 2.48 | 6.20 | 3.53 | 2.91 | 4.25 | 4.74 | 5.69 |
Earnings Yield |
0.00% | 12.43% | 0.00% | 3.79% | 10.44% | 4.41% | 1.99% | 3.38% | 3.62% | 5.25% |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 2.68% | 9.09% | 1.62% | 2.03% | 7.08% | 3.74% | 9.72% |
Revenue per Share |
0.81 | 1.24 | 1.70 | 2.13 | 3.39 | 2.96 | 3.59 | 4.77 | 5.79 | 6.95 |
Operating CF per Share |
0.17 | 0.32 | 0.59 | 0.51 | 0.91 | 0.57 | 0.72 | 1.18 | 1.01 | 1.33 |
Capex per Share |
0.00 | (0.09) | (0.14) | (0.34) | (0.20) | (0.48) | (0.56) | (0.61) | (0.71) | (0.61) |
Free Cash Flow per Share |
0.17 | 0.22 | 0.45 | 0.17 | 0.71 | 0.08 | 0.15 | 0.57 | 0.30 | 0.72 |
Cash per Share |
0.11 | 0.13 | 0.27 | 0.35 | 0.80 | 0.72 | 0.44 | 0.33 | 0.45 | 0.35 |
Shareholders Equity per Share |
0.34 | 0.63 | 0.86 | 1.16 | 2.11 | 2.40 | 2.51 | 2.97 | 3.44 | 3.69 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.34 | 0.63 | 0.86 | 1.16 | 2.11 | 2.40 | 2.51 | 2.97 | 3.44 | 3.69 |
Free Cash Flow |
6.29 | 8.45 | 17.07 | 6.28 | 27.32 | 3.35 | 5.91 | 21.71 | 11.64 | 28.08 |
Working Capital |
2.01 | 3.85 | 3.52 | 1.90 | 24.16 | 29.50 | 20.88 | 6.24 | 15.55 | 7.44 |
Capital Expenditures |
(1.64) | (3.57) | (5.30) | (12.81) | (7.79) | (19.15) | (21.83) | (23.50) | (27.45) | (23.83) |
Net Current Asset Value |
(0.60) | 3.05 | 2.01 | (11.09) | 16.31 | 24.17 | 19.79 | (2.63) | 9.11 | (7.14) |
EV/EBIT |
0.00 | 0.00 | 74,153.17 | 25.26 | 13.56 | 17.66 | 36.22 | 20.22 | 18.39 | 14.07 |
Capex to Sales |
0.00 | 0.08 | 0.08 | 0.16 | 0.06 | 0.16 | 0.16 | 0.13 | 0.12 | 0.09 |
Net Profit Margin |
3.92% | 17.42% | 14.75% | 10.62% | 24.01% | 7.80% | 4.48% | 5.60% | 5.02% | 5.53% |
Price to Operating Income |
0.00 | 0.00 | 74,154.08 | 25.36 | 14.67 | 19.81 | 38.36 | 20.60 | 19.22 | 14.13 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.10 | 0.12 | 0.12 | 0.12 | 0.17 | 0.18 | 0.23 | 0.30 | 0.34 | 0.37 |
Cash ROIC |
(30.14%) | (25.46%) | (17.65%) | (51.37%) | (16.48%) | (31.21%) | (34.87%) | (21.18%) | (24.02%) | (15.86%) |
Accounts Receivable Turnover |
4.23 | 6.45 | 6.92 | 7.88 | 10.99 | 8.64 | 9.22 | 10.81 | 10.34 | 10.66 |
Accounts Payable Turnover |
1.97 | 3.20 | 3.60 | 4.58 | 15.07 | 16.36 | 18.39 | 20.56 | 19.17 | 18.15 |
Inventory Turnover |
4.66 | 7.55 | 7.38 | 11.42 | 27.90 | 18.31 | 17.96 | 17.12 | 20.35 | 24.52 |
Average Days of Payables |
207.17 | 100.37 | 128.69 | 70.74 | 14.94 | 27.08 | 17.86 | 21.73 | 21.33 | 23.31 |
Days of Inventory on Hand |
78.08 | 48.41 | 63.14 | 20.47 | 16.47 | 20.54 | 24.09 | 24.05 | 17.32 | 16.04 |
Average Receivables |
7.28 | 7.27 | 9.31 | 10.19 | 11.95 | 13.54 | 15.06 | 16.93 | 21.68 | 25.36 |
Average Payables |
3.86 | 3.85 | 4.64 | 5.29 | 3.40 | 2.67 | 2.94 | 3.42 | 4.75 | 6.33 |
Average Inventory |
1.63 | 1.63 | 2.26 | 2.12 | 1.84 | 2.38 | 3.02 | 4.10 | 4.47 | 4.68 |
Average Assets |
31.15 | 31.10 | 45.67 | 68.12 | 97.58 | 115.26 | 117.50 | 135.97 | 165.98 | 188.11 |
Average Common Equity |
18.30 | 18.27 | 28.16 | 38.14 | 62.70 | 88.26 | 95.96 | 105.49 | 123.60 | 138.41 |
Columns are period end dates